Evidence map›Paper›PMID 37063258›Full record

ArticleFrontiers in pharmacology2023

Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy.

Nan-Rui Shi, Qi Wang, Jie Liu, Ji-Zhou Zhang, Bin-Lu Deng, Xiu-Min Hu, Jie Yang, Xin Wang, Xiang Chen, Yan-Qin Zuo and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Nan-Rui ShiInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Qi WangDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Jie LiuDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Ji-Zhou ZhangInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Bin-Lu DengDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Xiu-Min HuInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Jie YangDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Xin WangInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Xiang ChenDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yan-Qin ZuoInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Ting-Ting LiuDepartment of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Jia-Ling ZhengSchool of Clinical Medicine, Chengdu University of Traditional Medicine, Chengdu, China.
Xin YangInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Peter IllesInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Yong TangInternational Joint Research Centre on Purinergic Signalling, School of Acupuncture and Tuina/ School of Health and Rehabilitation, Chengdu University of Traditional Medicine, Chengdu, China.
Chengdu University of Traditional Chinese Medicine · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-nucleotide polymorphisms are connected with the risk of epilepsy on occurrence, progress, and the individual response to drugs. Progress in genomic technology is exposing the complex genetic architecture of epilepsy. Compelling evidence has demonstrated that purines and adenosine are key mediators in the epileptic process. Our previous study found the interconnection of P2Y12 receptor single-nucleotide polymorphisms and epilepsy. However, little is known about the interaction between the purine nucleoside A

Indexed as

A2A receptorCD73epilepsypurinergic receptorsingle-nucleotide polymorphism

Identifiers

PMID37063258
PMCPMC10090369
OpenAlexW4361303663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.